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ABSTRACT
Increasing attention is been given to Carica papaya seed due to its oil rich nature, and its medicinal value. Four feed diets consisting of 3, 5, 7, and 10 %
of the oil were composed and examined for its in-vivo effect on lipid and antioxidants status of female wistar rats compared to those fed with 5 %
groundnut oil based diet. The feeds were fed into the rats for 32 days, and examined for their lipid profile and antioxidant status in the liver and heart. Free
fatty acids were significantly reduced (P<0.05) by 3-10 % diets in the liver, and by 10 % diet in the heart. HMG-CoA/Mevalonate ratio in the liver was
significant increased (P<0.05) by the 7-10 % diets. All diets significantly increased (P<0.05) superoxide dismutase, peroxidase, and reduced glutathione
in liver. Lipid peroxidation in the heart was significantly increased (P<0.05) by the 3-7 % diets. Lipid peroxidation, and phospholipid in heart were
significantly reduced, and increased (P<0.05) respectively by 10 % diets. The biochemical status of rats fed with the Carica papaya seed oil based diets
generally remained comparable to those fed with the groundnut oil diet in the two organs. The Carica papaya seed oil exhibited better antioxidant
activities, and health benefits than the commonly consumed groundnut oil.
INTRODUCTION
Carica papaya is the most important species within the
Caricaceae family being cultivated widely for its consumption.
Nigeria is one of the major producers of Carica papaya in the
world [1]. Its seed have antimicrobial activity against Trichomonas
vaginalis trophozoites [2], bacteriostatic activity on both gram
positive and gram negative organisms that could be useful in
treating chronic skin ulcer [3]. Air dried papaya seed being
consumed offers a cheap, natural, harmless, readily available
monotherapy and preventive strategy against intestinal parasitosis
[4]. Benzylisothiocynate present in the seeds is the chief or sole
antihelmintic [5]. It was recently reported that fermented papaya
seed based diets may be good as food condiment, since it had no
side effect on the sexual development and reproductive functions
of female wistar rats [6].
Lipids are a broad group of naturally-occurring molecules which
includes fats, waxes, sterols, fat-soluble vitamins (such as vitamins
A, D, E and K), monoglycerides, diglycerides, phospholipids, and
others. The main biological functions of lipids include energy
storage, structural components of cell membranes, and as
important signaling molecules. However, antioxidants are
substances that offer protection to cell membranes and prevent
oxidative stress to the tissues of the body by neutralizing toxic
oxygen molecules and free radicals [7]. The action of one
antioxidant may therefore depend on the proper function of other
members of the antioxidant system. The amount of protection
provided by any one antioxidant will also depend on its
concentration, its reactivity towards the particular reactive
oxygen species being considered, and the status of the
antioxidants with which it interacts [7]. The relative importance
and interactions between these different antioxidants is a very
complex question, with the various metabolites and enzyme
systems having synergistic and interdependent effects on one
another [8]. Earlier work had shown papaya seeds to contain
high amount of oil [9]. There is no report yet on the effect of the
seed oil consumption in the heart and liver. This work was
therefore designed to assess the biochemical benefits of the oil
by determining the effects of diets composed from the oil on




There were significant reductions (P<0.05) in the total weight of
rat fed with the 7-10 % Carica papaya seed-oil based diets
compared to the control (Table 1). However, there were no
significant changes (P<0.05) in liver and weight of rats fed with
all the Carica papaya seed diets compared to the control (Table
1).
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Antioxidant activities in the liver of the rats fed on the
Carica papaya seed-oil based diets
Only the 3 % Carica papaya seed-oil based diet significantly
increased (P<0.05) peroxidase activities in the rat’s liver compared
to the baseline, and the control diets. The control diet, and all the
Carica papaya seed-oil based diets significantly increased
(P<0.05) lipid peroxidation in the rat’s liver compared to the baseline
diet fed rats. There was however no significant effect (P > 0.05) of
the Carica papaya seed oil diets on superoxide dismutase activity,
lipid peroxidation, and reduced glutathione level in rat liver
compared with the control diets (Table 2).
Antioxidant activities in the heart of the rats fed on
the Carica papaya seed-oil based diets
Lipid peroxidation in heart of rats fed with all the other Carica
papaya seed-oil based diet (3-7%) were significantly increased
(P<0.05) compared to that of the control diets. It was however
only the 10 % Carica papaya feed composition that significantly
reduced (P<0.05) lipid peroxidation compared to the control diet.
(Table 3). Both the control diet, and all the Carica papaya seed-
oil based diets significantly reduced (P<0.05) the lipid peroxidation
in the rat’s heart compared with the baseline diet. There were no
significant effects (P>0.05) of all the Carica papaya seed oil based
diets on peroxidase activity, superoxide dismutase activity, reduced
glutathione level in the heart compared with the control diet (Table
3).
Table 1: Level of feed intake and weight gain in rat fed with Carica papaya seed-oil based diet.
S/N Biochemical Weight Gain (%)
Parameters
Groundnut Carica Papaya Seed Oil Diets
oil diets (5 %)
                 Control 3% 5% 7% 10%
1. Whole body 20.601± 4.500 19.4± 4.0 13.4± 3.1 7.1± 1.8*a 9.9± 2.7*a (%)
2.             Liver (%) 38.507 ±8.914 24.420 ±7.554 43.448 ±10.665 45.150 ±7.842 21.858 ±8.613
3.             Heart (%)  40.637 ±7.593 24.227 ±9.698 31.885 ±8.900 37.650 ±7.924 27.690 ±7.087
4.             Food intake  10.57±0.58 11.43±0.40 11.77±0.84 10.33±1.18 10.03±1.14
 (g/day)†
1. Values within the same column with superscripts (*a) are significantly different at P < 0.05 compared to the control.
Table 2: Effects of the Carica papaya seed-oil based diet on the antioxidant activities in the rat liver.
S/N Biochemical Weight Gain (%)
Parameters
Groundnut Carica papaya seed oil diets
oil diets (5 %)
Baseline Control 3 % 5 % 7 % 10 %
1. Reduced 0.037 ±0.011 0.015 ±0.009 0.017 ±0.006 0.017 ±0.006 0.015 ±0.007 0.038 ±0.014
glutathione
(mmol/ml)
2. Lipid 2,884.135 3,597.598 4,095.673 3,937.503 3,294.710 3,624.520
±380.493*b ±331.084 ±449.621*b ±427.445*b ±661.719*b ±558.115
3. Peroxidase 0.161 ±0.033 0.196 ±0.008 0.231±0.018*ab 0.219 ±0.042 0.209 ±0.017 0.190 ±0.024
activity (unit/ml
enzyme)
4. Superoxide 52.500 ±11.080 60.000 ±13.670 60.000 ±7.140 70.000 ±10.140 70.000 ±9.260 50.000 ±8.260
Dismutase (unit
/ml enzyme)
1. Values within the same column with superscripts (*a) are significantly different at P < 0.05 compared to the control.
2. Values within the same column with superscripts (*b) are significantly different at P < 0.05 compared to the baseline.
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Table 3: Effects of the Carica papaya seed-oil based diet on the antioxidant activities in the rat heart.
S/N Biochemical Weight Gain (%)
Parameters
Groundnut Carica papaya seed oil diets
oil diets (5 %)
Baseline control 3% 5% 7% 10%
1. Reduced 0.088 ±0.045 0.082 ±0.011 0.073 ±0.004 0.090 ±0.009 0.090 ±0.016 0.075 ±0.008
glutathione
(mmol/ml)
2. Lipid 4,048.558 456.733 3,368.850 3,510.098 3,547.118 1,975.483
 peroxidation ±552.783 2, ±304.304*b ±457.510*ab ±481.663*ab ±147.668*ab ±459.320*ab
(nmol/ml)
3. Peroxidase 0.060 ±0.039 0.083 ±0.032 0.071 ±0.042 0.076 ±0.036 0.065 ±0.035 0.109 ±0.012
activity (unit
/ml enzyme)
4. Superoxide 80.000 ±8.16 65.000 ±12.91 81.000 ±0.00 65.000 ±23.80 67.500 ±22.17 65.000 ±12.91
Dismutase
(unit/ml enzyme)
1. Values within the same column with superscripts (*a) are significantly different at P < 0.05 compared to the control.
2. Values within the same column with superscripts (*b) are significantly different at P < 0.05 compared to the baseline.
Lipid Profile in the Rats Liver
All the Carica papaya seed oil diets significantly reduced (P<0.05)
free fatty acid levels in the liver (Table 4). Also, significant increases
(P<0.05) in HMG-CoA/Mevalonate ratio were manifested in liver
of rat fed on the 7 % and 10 % Carica papaya seed-oil diets
compared to control (Table 4). There were no significant effects
(P>0.05) of the Carica papaya seed oil based diet consumption
on cholesterol, triglycerides, and phospholipid levels in the liver
compared with the control (Table 4).
Lipid Profile in Rats Heart
The Carica papaya seed oil (10%) based diets significantly
increased (P<0.05) phospholipid levels in the heart of rats
compared with both the baseline, and the control diets (Table 5).
The free fatty acids in the heart was mainly significantly reduced
(P<0.05) by the 10 % diets. The free fatty acids levels in both
control diets, and Carica papaya seed oil fed rats were
significantly increased (P<0.05) compared to that of the baseline
diet. There were no significant effects (P>0.05) of all the Carica
papaya seed oil based diet consumption on cholesterol, and
triglycerides in the heart compared with the control diet (Table 5).
DISCUSSION
Weight changes
The body weight gain (growth) was reduced at high Carica
papaya seed oil concentration (7-10 %) in diets. This oil can
therefore be used not only to control glucose homeostasis in
diabetes mellitus but to control dyslipidemia and obesity alike. It
is well established that there is a strong link between diabetes
mellitus, dyslipidemia, obesity, hypertension and ischemic heart
disease [10]. Some side effects of the oil at high concentration (10
%) in the brain that was attributed to the alpha-sitoterol component
of the oil limiting cholesterol from gaining access to the brain
through the blood brain barrier [11]. We cannot preclude the
possibility of toxicity as a result of the high dosage of the Carica
papaya seed oil, but the level of feed intake/day of the various
animal group (Table 1) indicates that there were no loss of appetite
as a result of the Carica papaya seed oil consumption.
Antioxidant
In mammalian cells, glutathione and the glutathione peroxidases
constitute the principal antioxidant defense system [12]. Lipid
peroxidation was induced by the Carica papaya seed oil in a similar
manner as that of groundnut oil in the liver. Carica papaya seed
oil at high concentration (10 %) could be more effective in reducing
lipid peroxidation than groundnut oil. The reverse was however
the case at concentration below the 10 % composition. There is
low activity of antioxidants in the food or diet when there is high
lipid peroxidation. The higher the lipid peroxidation, the lower the
antioxidant activity of the Carica papaya seed oil. The amount of
protection provided by any one antioxidant will also depend on
its concentration, its reactivity towards the particular reactive
oxygen species being considered, and the status of the
antioxidants with which it interacts (7). Polyphenols antioxidants
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in the oil was earlier reported at a concentration of 119.917 ± 2.626
µg/ml [13]. The Carica papaya seed oil manifested similar
antioxidant metabolic effect on both superoxide dismutase and
peroxidase activities which are
Table 4: Effects of the Carica papaya seed-oil based diet on lipid profile in the rat liver.
S/N Biochemical Weight gains (5 %)
Parameters
Groundnut Carica Papaya Seed Oil Diets
oil diets ( 5 %)
Baseline Control 3% 5% 7% 10%
1 Cholesterol 6.12± 1.95 10.750 ±3.200 13.750 ±3.910 10.500 ±2.850 9.000 ±1.070 6.500 ±1.950
 (mg/dl)
2. Triglycerides 77.7± 5.6 64.000 ±13.540 49.500 ±8.410 74.750 ±6.770 83.000 ±6.050 45.500 ±5.510
(mg/dl)
3. Phospholipid 49.80± 4.60 74.20 ±4.81 68.50 ±5.04 77.2 ±13.84 71.75±13.62 63.75±8.69
(mg/dl)
4. Free fatty acids 459.5± 5.1 495.031 ±35.942 306.868 354.792 387.147 348.940
(mg/ml) ±32.962*ab ±25.380*ab ±18.256*ab ±48.463*ab
5. HMG-CoA/ 0.279± 0.089 0.342 ±0.017 0.381 ±0.019 0.394 ±0.031 0.405 ±0.021*ab 0.520 ±0.036*ab
Mevalonate ratio
1. Values within the same column with superscripts (*a) are significantly different at P < 0.05 compared to the control.
2. Values within the same column with superscripts (*b) are significantly different at P < 0.05 compared to the baseline.
Table 5: Effects of the Carica papaya seed-oil based diet on lipid profile in the rat heart.
S/N Biochemical Weight gains (5 %)
Parameters
Groundnut oil (5 %) Carica Papaya Seed Oil Diet
Baseline Control 3% 5% 7% 10%
1. Cholesterol 12.250 ±4.920 15.500 ±3.510 13.250 ±0.960 12.000 ±4.080 15.000 ±1.830 15.750± 2.87
(mg/dl)
2. Triglycerides 86.000 ±11.950 86.000 ±12.760 78.000 ±14.020 86.250 ±7.800 81.000 ±5.290 116.000
(mg/dl) ±20.620
3. Phospholipid 1,207.500 1,375.500 928.750 1022.500 1,187.750 1,844.250
(mg/dl) ±399.480 ±204.530 ±266.590 ±149.660 ±348.480 ±279.130*ab
4. Free fatty acids 72.549±38.744 178.997 168.618 144.081 140.663 120.473
 (mg/ml) ±23.747*b ±14.133*b ±19.888*b ±18.759*b ±12.521*ab
1. Values within the same column with superscripts (*a) are significantly different at P < 0.05 compared to the control.
2. Values within the same column with superscripts (*b) are significantly different at P < 0.05 compared to the baseline.
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enzymatic antioxidants, and on reduced glutathione level in both
the rat’s heart and liver (Table 2 & 3). Liver is the drug (chemical,
nutrients) processing centre. Metabolism of most drug, nutrients,
or chemical that is taken in to the body always starts from the liver
first before it gets to the other part of the body. This may explain
the lack of effect of peroxidase, superoxide dismutase, reduced
glutathione in the heart, and the conspicuous effect of the Carica
papaya seed oil in the liver. The Carica papaya seed oil however
exhibited potent antioxidant activities.
Lipid profile
Carica papaya seed oil showed similar biochemical effect on
cholesterol, triglyceride and phospholipid metabolism to that of
groundnut oil in the rat liver. It also manifested similar effect on
cholesterol and triglycerides metabolism in the heart. All the
Carica papaya seed oil diets (3-10 %) consumption however led
to reductions on free fatty acids in the liver. The free fatty acid
was however mainly reduced in the heart at high concentration
(10 %). The reduction of free fatty acids (Table 5) in the heart by
the high Carica papaya seed oil administration (10 %) could either
be due to low supply of plasma free fatty acids due increased
usage, or increased oxidation of free fatty acids for ATP production
in the heart [14]. However, the reductive effect by the high Carica
papaya seed oil administration can be limited to that of the
increased free fatty acids oxidation since there were no earlier
effects of the seed oil administration in the plasma [11]. The
reduction of free fatty acids was however more pronounced in the
liver (Table 4) as it was manifested even at very low Carica papaya
seed oil (3 %) administration. Carica papaya seed oil may therefore
prevent hypercholesterolemia since it showed ability to prevent
fatty acid accumulation that could be a primary substrate for
cholesterol synthesis [15]. A positive relationship between
gluconeogenesis and lipogenesis has been well documented in
literature. Lipogenesis is inhibited directly by elevated fatty acids
concentration within physiological range [16]. Previous human
studies have also shown papaya to slow down the heart beat,
and reduce blood pressure [17]. Therefore the oil can be
considered good for treating hypertensive patients.
Phospholipids are important cellular components, and their
metabolism is under several tiers of control. Alterations in the
composition of phospholipids in the membrane may affect cellular
processes such as the transport of Na+ and K+, the transduction
of biological signal across the membrane, and the release of
arachidonic acid for the production of prostaglandins and
leukotrienes [18]. Phospholipid concentration in the heart was
however increased at 10 % Carica papaya seed oil diet
consumption (Table 5). The increased free fatty acids in the heart
(Table 5) as a result of the 10 % Carica papaya seed oil consumption
could further be attributed to the observed increase in the hearts
phospholipid. The oil could also be facilitating the absorption of
nutrients (vitamins A, E, and folate) that increased phospholipid
biosynthesis in the heart [19]. The increased total phospholipids
in hearts of rats could be attributed to the ability of the Carica
papaya seed oil to facilitate its synthesis by the diphosphocholine-
ethanolamine pathway [19].
The higher the HMG-CoA/Mevalonate ratio, the lower the activity
of the HMG-CoA reductase in the cholesterol synthesis and vice-
versa [20]. Therefore, Carica papaya seed oil consumption
possessed ability to reduce the accumulation or synthesis of
cholesterol in the liver. This ability was earlier reported in the
brain [11]. This explains the continual decrease in cholesterol
concentration (Table 4) as the papaya seed oil concentration
increases in diets. Although, the changes in cholesterol
concentration were not remarkably noticed.
In conclusion, the Carica papaya seed oil is a potent antioxidant
source with ability to improve the lipid and antioxidant status of
the rats. The seed oil can also be used for treating obesity, and
diseases like hypercholesterolemia due to its reducing effect on
cholesterol levels. It can also be effectively used to reduce the
lipid peroxidation in both the liver and the heart mainly at high
concentration. The oil therefore could be an effective tool for
treating liver and heart diseases under controlled administration.
EXPERIMENTALS
Chemicals and Reagents
The following chemicals used: hydrogen peroxide (H2O2),
pyrogallol, trichloroacetic acid (TCA), 5, 5’- dithio-bis (2-
nitrobenzoic acid) (DTNB), epinephrine and 2-thiobarbituric acid
were products of Sigma Aldrich Chemicals (USA); Ethylene
diamine tetraacetic acid disodium salt (Na2 EDTA.2H2O), TBA-
TCA-HCl reagent, triton X-100, isopropanol, cuprizone reagent,
triethanolamine ammonium hydroxide, n-hexane, palmitic acid,
sodium arsenate, physiological saline (99 % saline), hydroxylamine
hydrochloride (NH2OH.HCl) were products of British Drug Houses
chemicals limited, Poole, England; also heparin was a product of
Choongwae Pharma Corporation (Korea). Reagent Diagnostic kits
for triglyceride and cholesterol were products of Cromatest®
diagnostics, Joaquim Costal, Montgat, Barcelona, Spain. All
chemicals used were of analytical grade.
Materials
Wholesome ripe and mature Carica papaya fruits were purchased
at a local fruit market. The fruits were identified at the Applied
Biology and Biotechnology Unit of Biological Sciences
Department, Covenant University (CU), and deposited (Voucher
number: FHI108906) at the Herbarium unit of Forest Research
Institute, Ibadan, Nigeria. The fruits were cut into longitudinal
halves and the wet seeds were separated out. These seeds were
then gently but thoroughly rinsed with distilled water, and
completely oven dried at 55 oC for 40 hours. The dried seeds were
pulverized into a fine powder using a mortar and pestle. The oil
was extracted from the pulverized Carica papaya seeds with a
Soxhlet apparatus (J.P. Selecta model) using n-hexane as the
extracting solvent at 69 oC. The extract was then subjected to pure
recovery using a rotary evaporator at 69 oC. This yielded fine,
clear golden-yellow oil. The oil was kept in an air and water proof
container, and stored in a biofreezer at -20 oC until when required.
Experimental Animals
Healthy, 24-four-week-old female wistar albino rats (90-120 g) were
purchased from the animal house of the University of Agriculture,
Nig. J. Nat. Prod. and Med. Vol. 16 201216
Abeokuta, Ogun State, Nigeria. The rats were housed in well
ventilated cages at the light proofed CU animal house. The
experiment conducted following the Covenant University ethical
committee guidelines. The animal house and its facilities were
designed to prevent animals escaping and to prevent wild animals
and insects from entering the animal house. The cages were
cleaned twice every day. Suffocation in a diethyl ether vapour
filled compartment was used to ensure the humane killing of the
experimental animals. Animal surgeries were performed in a room
different from where the animals were housed. Saw-dust was used
as beddings for the animal house. The concentrations of the oil in
diets were selected such that the recommended 5% composition
was accommodated, and the others representing slightly lower
(3%), slightly higher (5%), or too higher (10%) concentrations
than the recommended.
Feed Formulation of Experimental Rat Diet
Four Carica papaya seed diets (3 %, 5 %, 7 %, and 10 %), and 5 %
groundnut based diet (control) were composed as described by
Afolabi, Akuiyibo, Rotimi and Adeyemi [11]. All the rat feed diets
were composed with a mixture of flour binder (80g), groundnut
cake (50g), fish meal (2.5g), soya meal (65g), wheat offals (7.5g),
bone meal (7.5g), pre-mix (1g), salt (1g), methionine (0.25g), and
lysine (0.25g). Both the control and the baseline diets also
contained white maize (192.5g) and groundnut oil (25g). The 3%,
5%, 7%, and 10% Carica papaya seed oil diets contained 202.5g
and 15g, 192.5g and 25g, 182.5g and 35g, and 167.5g and 50g of
white maize and Carica papaya seed oil respectively. Each flour
mix was thereafter compressed into a cylindrically shaped cake
before air-drying.
Experimental Design
Twenty four rats were randomly arranged in cages such that each
cages contained four rats. All the rats were thereafter left to
acclimatize for 2 weeks. They were fed ad libitum with their
respective diets except for the 24 hours fasting period prior to
their being sacrificed. The rats in ‘group 0’ fed with 5 % groundnut
oil based diet, but sacrificed just at the beginning of the feeding
experiment (day 0) were termed as ‘baseline’. The ‘Group 0’ served
as the baseline control to ascertain the initial biochemical status
of the rats. The rats in ‘group 1’ fed with 5 % groundnut oil based
diet, but sacrificed at the end of the 32 days feeding experiment
were termed as ‘control’. ‘Group 2’ rats were fed with 10 %, ‘Group
3’ rats with 7 %, ‘Group 4’ rats with 5 %, and ‘Group 5’ rats with 3
% Carica papaya seed oil based diet.
Four (4) rats from each group were sacrificed thirty-two (32) days
after feeding the rats with their respective diets. The liver and
heart were removed rinsed in potassium chloride solution (0.05
M) and then placed in tabs. They were also excised, weighed and
10 % homogenate was prepared in 0.25 M sucrose buffer.  The
homogenate was used for antioxidants determination
Lipids were extracted with chloroform–methanol mixture (2:1, v/v)
as described by Folch, et al. [21]. Saline/arsenate homogenate
was used in the case of the liver as described by Rao and
Ramakrlshnan [22]. The extracted samples were thereafter used
for further lipid profile analysis.
Weight changes: The weight of each animal and that of the two
organs were was determined at day 0 and day 32 of the experiment.
The changes in weight were expressed as a percentage of the
original weight at day 0.
ANALYTICAL METHODS
Bio-makers of oxidative stress
The concentration of thiobarbituric acid-reactive substances
(TBARS) was determined colorimetrically by the method of Buege
and Aust [23]. The reduced glutathione concentration was
determined as described by Ellman (24). Peroxidase (PER) activity
was assayed following the method of Wever, et al. [25]. The PER
activity was calculated using the molar extinction coefficient of
oxidized pyrogallol (4.5 liter/mol.).
Superoxide dismutase (SOD) activity in homogenised samples
was determined by the method of Misra and Fridovich [26]. The
increase in absorbance at 480 nm was monitored and 1 unit of
SOD activity was given as the amount of SOD necessary to cause
50 % inhibition of the oxidation of adrenaline. SOD levels were
expressed as units/mg protein. The protein concentration was
determined by means of the biuret reaction, as described by
Gornall, et al. [27].
Lipid profiles analysis
Total phospholipids in the organs were extracted with a
chloroform–methanol mixture (2:1, v/v) as described by Folch,
Lees and Stanley [21]. The phospholipid content was then
determined as described by Stewart [28]. However, an aliquot of
the phospholipid extract was evaporated to dryness at 60 æ%C. Its
absorbance was read at 488 nm, and the phospholipid
concentrations were then determined using a phospholipid
standard as reference.
Free fatty acids (FFA) in plasma were determined according to the
method described by Brunk and Swanson [29]. The concentrations
of FFA in the plasma samples were extrapolated from a palmitic
acid standard curve prepared using the same procedure.
Cholesterol concentration was determined spectrophotometrically
using 1ml of commercially available cholesterol kit reagent
according to the method of Folch, Lees and Stanley [21].
Triglyceride concentrations in the chloroform–methanol extracts
of the homogenates were determined spectrophotometrically
following the procedure described by Kriketos, et al. [30]. HMG
CoA/ Mevalonate ratio was also determined as described by Rao
and Ramakrlshnan [22]. The optical density was taken at 540 nm
after allowing the mixture to stand for 10 minutes. A similarly treated
saline/arsenate solution was used as blank. The same procedure
stated above was also carried out for mevalonate determination
except that freshly prepared hydroxylamine reagent was used for
mevalonate test which is different from that of HMG-CoA test.
Statistical evaluation
Results were expressed as mean ± standard deviation. One-way
analysis of variance (ANOVA) followed by the Duncan Multiple
Range Test (DMRT) were used to analyze the results, with P <
0.05 considered significant.
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